Literature DB >> 4009117

C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro.

F A Robey, K D Jones, A D Steinberg.   

Abstract

We have studied the interaction of C-reactive protein (CRP)-chromatin complexes with serum. The amount of chromatin solubilized by serum is directly proportional to the amount of CRP present. Serum minus C3 did not appreciably solubilize chromatin within the time allowed in these experiments regardless of the amount of CRP present. This indicates that, in addition to CRP, complement is critical to the solubilization process. Studies using genetically C2-deficient serum and purified C2 indicate that the classical complement pathway is primarily involved in the solubilization, however, there may be minor involvement by the alternative pathway. We used an enzyme-linked immunosorbent assay to determine the amounts of CRP in plasma from eight patients with systemic lupus erythematosus; two of the eight had levels of CRP far lower than previously reported for normal individuals, and an additional sample had antibodies reactive with CRP. Together, these results suggest that one of the functions of CRP is to mediate the removal of exposed nuclear DNA by complement-dependent solubilization of chromatin. A defect in this mechanism could (a) facilitate the production of antibodies against chromatin components exposed due to tissue damage or (b) contribute to immune complexes containing the chromatin components released from damaged tissue because they are not rapidly cleared.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009117      PMCID: PMC2187628          DOI: 10.1084/jem.161.6.1344

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Clinical and experimental studies on C-reactive protein (acute phase protein).

Authors:  P HEDLUND
Journal:  Acta Med Scand Suppl       Date:  1961

2.  Level of C-reactive protein as a measure of acute myocardial infarction.

Authors:  I G KROOP; N H SHACKMAN
Journal:  Proc Soc Exp Biol Med       Date:  1954-05

3.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A new sensitive assay for the calcium-dependent binding of C-reactive protein to phosphorylcholine.

Authors:  T Tanaka; F A Robey
Journal:  J Immunol Methods       Date:  1983-12-30       Impact factor: 2.303

6.  Serum C-reactive protein levels in disease.

Authors:  J J Morley; I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide.

Authors:  J E Volanakis
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  Activation and regulation of the first complement component.

Authors:  N R Cooper
Journal:  Fed Proc       Date:  1983-01

9.  Localizing of C-reactive protein in synovium of patients with rheumatoid arthritis.

Authors:  J D Gitlin; J I Gitlin; D Gitlin
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

10.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01
View more
  26 in total

Review 1.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms.

Authors:  C Trautwein; K Böker; M P Manns
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 3.  Bovine and canine acute phase proteins.

Authors:  P D Eckersall; J G Conner
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

4.  Functional effects of CRP binding to nuclei.

Authors:  E G Shephard; P D van Helden; M Strauss; L Böhm; F C De Beer
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

5.  Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity.

Authors:  A P Cairns; A D Crockard; J R McConnell; P A Courtney; A L Bell
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

6.  Why measure C reactive protein?

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

7.  Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.

Authors:  S A Bell; H Faust; A Schmid; M Meurer
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

8.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

9.  Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis.

Authors:  Qiu-Yu Li; Hai-Yun Li; Ge Fu; Feng Yu; Yi Wu; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

10.  Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study.

Authors:  Osvaldo P Almeida; Paul E Norman; Richard Allcock; Frank van Bockxmeer; Graeme J Hankey; Konrad Jamrozik; Leon Flicker
Journal:  Int J Epidemiol       Date:  2009-05-11       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.